(Q40036736)

16 September 2017

Comparative cytotoxicity of C-1311 in colon cancer in vitro and in vivo using the hollow fiber assay (English)

1 reference

16 September 2017

1 reference

N Alami

1

1 reference

16 September 2017

J Paterson

2

1 reference

16 September 2017

S Belanger

3

1 reference

16 September 2017

S Juste

4

1 reference

16 September 2017

C K Grieshaber

5

1 reference

16 September 2017

B Leyland-Jones

6

1 reference

16 September 2017

1 October 2007

1 reference

16 September 2017

Journal of Chemotherapy

1 reference

16 September 2017

19

1 reference

16 September 2017

546-553

1 reference

16 September 2017

5

1 reference

16 September 2017

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

Novel chemotherapeutic agents in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

The changing face of chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU).

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

Capecitabine: preclinical pharmacology studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

Preclinical evaluation of novel imidazoacridinone derivatives with potent activity against experimental colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

RPR-115135, a farnesyltransferase inhibitor, increases 5-FU- cytotoxicity in ten human colon cancer cell lines: role of p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

Levamisole Potentiation of Fluorouracil Antiproliferative Activity Mimicked by Orthovanadate, an Inhibitor of Tyrosine Phosphatase

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

Antitumor effects of 5-fluorouracil on human colon cancer cell lines: antagonism by levamisole

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

Sequence-dependent activity of the irinotecan-5FU combination in human colon-cancer model HT-29 in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

New highly lipophilic camptothecin BNP1350 is an effective drug in experimental human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

Nanoparticles of biodegradable polymers for clinical administration of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2007.19.5.546

10.1179/JOC.2007.19.5.546

21 January 2018

Identifiers

DOI

1 reference

16 September 2017

1 reference